Atlasi et al. [76] found that bladder transitional cell carcinoma with high Oct3/4 expression has faster tumor progression and shorter tumor-related survival time than superficial bladder transitional cell carcinoma with medium and low expression of Oct3/4. The gene discussed is POU5F1; the disease is bladder transitional cell carcinoma.